ApoyoDravet’s efforts seek to accelerate scientific research projects, driving the advancement and practical application of science in the field of rare epilepsy diseases. In this context, it heads a collaborative network of researchers (the INDRE network), to whom it offers advising services, the promotion of knowledge and technology transfer, and assistance financing projects.

The association currently supports 14 research groups and more than 50 researchers working at the cutting edge of technology in fields such as genetic techniques, cellular therapy, machine learning, artificial intelligence, nanotechnology, drug development, neuroinflammation and brain organoids, among others.

Its initiatives include:
• the International Research Network on Dravet Syndrome and Refractory Epilepsy (INDRE).
• the Epilepsy Social Research Unit [Unidad de Investigación Social sobre Epilepsias].
• ApoyoDravet’s clinical studies, trials and programs.
• conventions and scientific conferences.
• its cognitive intervention platform.